Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 1 Neoplasms 1 Cardiovascular Abnormalities 1 Cardiotoxicity 1

Interventions

Trastuzumab 2 Ivabradine 2 Exercise 2 Echocardiography 2 Bisoprolol 2 salicylhydroxamic acid 1 sacubitril and valsartan sodium hydrate drug combination 1 mitoquinone 1 epicatechin gallate 1 dapagliflozin 1 candesartan 1 Trimetazidine 1 Therapeutics 1 Surveys and Questionnaires 1 Spironolactone 1 Silymarin 1 Secondary Prevention 1 Restraint, Physical 1 Ramipril 1 Radiotherapy 1 Perindopril 1 Neoadjuvant Therapy 1 Nebivolol 1 Hydroxymethylglutaryl-CoA Reductase Inhibitors 1 Fluorouracil 1 Epirubicin 1 Docetaxel 1 Cyclophosphamide 1 Cisplatin 1 Carvedilol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Cardiotoxicity × Carvedilol × Clear all

NCT04939883 2024-06-28

CardioTox

Hospital Sirio-Libanes

Phase 4 Unknown

Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡